EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieStudienprotokoll

The ENGAGE Protocol: ENzymatic debridement with NexoBrid® Followed by Grafting After Graded early Excision - A Retrospective Cohort Study

Giuseppe A G Lombardo, Marco Mollica, Serafina Pepe, Dario Melita, Rosario Ranno, Paolo Marchica iD

Journal of Burn Care & Research · 2026

DOI: 10.1093/jbcr/irag030 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Burn Care & Research, 2026. Verfasst von Giuseppe A G Lombardo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Burn and Plastic Surgery Unit, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Via Messina 829, 95126, CT, Italy. Hauptthemen laut MEDLINE: Debridement, Burns, Skin Transplantation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzymatic debridement with NexoBrid® has become a cornerstone of modern burn care due to its selective tissue-sparing properties. However, the optimal timing and strategy for surgical intervention following enzymatic treatment remain debated. We aimed to evaluate the clinical outcomes of the ENGAGE protocol (ENzymatic debridement with NexoBrid®, followed by Grafting After Graded early Excision), a structured algorithm integrating enzymatic debridement with scheduled wound reassessment and selective early excision. This before and after observational study included adult burn patients treated with NexoBrid® between January 2020 and October 2025 (2020–2022 received standard NexoBrid® management; 2023–2025 received the ENGAGE protocol, featuring day-7 reassessment and selective excision). Endpoints included autologous grafting rate, length of hospital stay (LOS), mortality, and number of surgical procedures. Eighty-eight patients were analyzed (27 standard NexoBrid® management, 61 ENGAGE). Baseline characteristics and burn etiologies were comparable. The ENGAGE group showed a significantly shorter LOS (mean±SD: 24±13.8 vs 32±19.2 days, median: 23 vs 27 days, p=0.03) with no increase in grafting rate (60.7% vs 59.3%, p=0.54) or mortality (9.8% vs 7.4%, p>0.5). The number of surgical procedures per patient was higher in the ENGAGE group (4.36±3.82 vs 2.74±3.82, p=0.029), reflecting planned early reassessment and targeted intervention rather than increased morbidity. The ENGAGE protocol reduces hospital stay without compromising grafting or survival outcomes. By incorporating early, biologically guided excision after enzymatic debridement, it offers a structured and effective refinement of modern burn wound management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DebridementBurnsSkin TransplantationHumansRetrospective StudiesFemaleMaleMiddle AgedLength of StayAdultTreatment Outcome

Stichwörter der Autor:innen

NexoBridburn surgeryearly excisionenzymatic debridementhospital length of staywound management

Autor:innen und Institutionen

  • Burn and Plastic Surgery Unit, Azienda Ospedaliera per l'Emergenza Cannizzaro, Catania, Via Messina 829, 95126, CT, Italy.
  • Università degli Studi di Enna Kore, Enna, Piazza dell'Università, 94100, EN, Italy.

ORCID-Profile: Paolo Marchica

Zitieren

APA

Lombardo, G. A. G., Mollica, M., Pepe, S., Melita, D., Ranno, R., & Marchica, P. (2026). The ENGAGE Protocol: ENzymatic debridement with NexoBrid® Followed by Grafting After Graded early Excision - A Retrospective Cohort Study. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irag030

Vancouver

Lombardo GAG, Mollica M, Pepe S, Melita D, Ranno R, Marchica P. The ENGAGE Protocol: ENzymatic debridement with NexoBrid® Followed by Grafting After Graded early Excision - A Retrospective Cohort Study. Journal of Burn Care & Research. 2026. doi:10.1093/jbcr/irag030

BibTeX
@article{Lombardo2026,
  author = {Lombardo, Giuseppe A G and Mollica, Marco and Pepe, Serafina and Melita, Dario and Ranno, Rosario and Marchica, Paolo},
  title = {The ENGAGE Protocol: ENzymatic debridement with NexoBrid® Followed by Grafting After Graded early Excision - A Retrospective Cohort Study},
  journal = {Journal of Burn Care & Research},
  year = {2026},
  doi = {10.1093/jbcr/irag030}
}
Kostenlos starten →